We also identified other deletions associated with higher HRD in multiple cancer types, such as XRCC2/3 and BARD1 deletion in BLCA, TP53BP1, and RAD51 deletion in OV and LUAD, and CHEK1 deletion in TCGT and SKCM, etc. (Figure 4C). Here, XRCC2 is linked to cancer.